A metabolic cell death program downstream of SARM1 couples NAD + depletion to BAX activation and APAF1 degradation
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2522444122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Weilong Pan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China. Hauptthemen laut MEDLINE: bcl-2-Associated X Protein, Apoptotic Protease-Activating Factor 1, Armadillo Domain Proteins, NAD. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinease Ministry of Science and Technolgy, | Natural Science Foundation of Beijing Municipality (), 北京市科学技术委员会 | Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
SARM1 is a neuronal Nicotinamide adenine dinucleotide (NAD + ) hydrolase that drives axonal degeneration and neuronal death by depleting NAD + , yet how NAD + loss triggers axon loss and cell death has remained unclear. Here, we define a nonapoptotic death program downstream of endogenous SARM1 activation and NAD + loss using a genetically tractable nonneuronal eHAP cell model. Upon NAD + depletion, BAX is activated but caspase activation is suppressed due to APAF1 degradation via the E3 ligase HERC4, effectively uncoupling mitochondrial outer membrane permeabilization from apoptosome formation. Mechanistically, NAD + depletion inhibits mTOR/AKT signaling, destabilizing MCL1 and relieving BAX from repression. We further identified Neurofibromatosis type II, NF2, as a regulator that promotes SARM1 transcription through the Hippo–YAP/TAZ pathway. The SARM1-dependent BAX activation and the role of NF2 in axon degradation were validated in neuronal models of axon degeneration. Together, these findings reveal how SARM1-driven metabolic collapse rewires cell death execution, positioning BAX, MCL1, APAF1, NF2, and HERC4 as core effectors in a nonapoptotic degenerative pathway linking metabolic stress to neurodegeneration
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
- National Institute of Biological Sciences, Beijing 102206, China.
ORCID-Profile: Xiaodong Wang
Förderung
- Chinease Ministry of Science and Technolgy
- | Natural Science Foundation of Beijing Municipality ()
- 北京市科学技术委员会 | Natural Science Foundation of Beijing Municipality
Zitieren
APA
Pan, W., Guo, D., Liu, D., & Wang, X. (2025). A metabolic cell death program downstream of SARM1 couples NAD + depletion to BAX activation and APAF1 degradation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2522444122
Vancouver
Pan W, Guo D, Liu D, Wang X. A metabolic cell death program downstream of SARM1 couples NAD + depletion to BAX activation and APAF1 degradation. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2522444122
BibTeX
@article{Pan2025,
author = {Pan, Weilong and Guo, Dejia and Liu, Daiyuan and Wang, Xiaodong},
title = {A metabolic cell death program downstream of SARM1 couples NAD + depletion to BAX activation and APAF1 degradation},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2522444122}
}
EUVIMED